Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,881 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort study.
Jinno S, Onishi A, Hattori S, Dubreuil M, Ueda Y, Nishimura K, Okano T, Yamada H, Yamamoto W, Murata K, Onizawa H, Ebina K, Maeda Y, Son Y, Amuro H, Hara R, Hata K, Shiba H, Katayama M, Watanabe R, Hashimoto M, Saegusa J. Jinno S, et al. Among authors: murata k. Rheumatology (Oxford). 2024 Feb 6:keae081. doi: 10.1093/rheumatology/keae081. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38317442
Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.
Ebina K, Hashimoto M, Yamamoto W, Hirano T, Hara R, Katayama M, Onishi A, Nagai K, Son Y, Amuro H, Yamamoto K, Maeda Y, Murata K, Jinno S, Takeuchi T, Hirao M, Kumanogoh A, Yoshikawa H. Ebina K, et al. Among authors: murata k. Arthritis Res Ther. 2019 Apr 11;21(1):91. doi: 10.1186/s13075-019-1880-4. Arthritis Res Ther. 2019. PMID: 30971306 Free PMC article.
Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.
Ebina K, Hashimoto M, Yamamoto W, Hirano T, Hara R, Katayama M, Onishi A, Nagai K, Son Y, Amuro H, Yamamoto K, Maeda Y, Murata K, Jinno S, Takeuchi T, Hirao M, Kumanogoh A, Yoshikawa H. Ebina K, et al. Among authors: murata k. Arthritis Res Ther. 2019 May 6;21(1):114. doi: 10.1186/s13075-019-1897-8. Arthritis Res Ther. 2019. PMID: 31060597 Free PMC article.
Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study.
Ebina K, Hashimoto M, Yamamoto W, Hirano T, Hara R, Katayama M, Onishi A, Nagai K, Son Y, Amuro H, Yamamoto K, Maeda Y, Murata K, Jinno S, Takeuchi T, Hirao M, Kumanogoh A, Yoshikawa H. Ebina K, et al. Among authors: murata k. PLoS One. 2019 May 8;14(5):e0216624. doi: 10.1371/journal.pone.0216624. eCollection 2019. PLoS One. 2019. PMID: 31067271 Free PMC article.
Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis.
Tomizawa T, Ito H, Murata K, Hashimoto M, Tanaka M, Murakami K, Nishitani K, Azukizawa M, Okahata A, Doi K, Saito M, Furu M, Hamaguchi M, Mimori T, Matsuda S. Tomizawa T, et al. Among authors: murata k. Arthritis Res Ther. 2019 Jul 15;21(1):174. doi: 10.1186/s13075-019-1956-1. Arthritis Res Ther. 2019. PMID: 31307521 Free PMC article.
Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor 1 Predicts the Changes of Rheumatoid Factor Titers in Rheumatoid Arthritis.
Okahata A, Ito H, Furu M, Ishikawa M, Fujii T, Hashimoto M, Tanaka M, Morita Y, Azukizawa M, Tomizawa T, Doi K, Nishitani K, Murata K, Yoshitomi H, Mimori T, Matsuda S. Okahata A, et al. Among authors: murata k. J Clin Rheumatol. 2020 Oct;26(7):295-300. doi: 10.1097/RHU.0000000000001116. J Clin Rheumatol. 2020. PMID: 31397763
Feasibility of patient-oriented ultrasound joint selection: Cross-sectional observational study on rheumatoid arthritis.
Kawahara R, Nakabo S, Shimizu M, Yamamoto H, Sasai T, Nishida Y, Funakoshi S, Gon Y, Taniguchi M, Nakajima T, Hiwa R, Hashimoto M, Tomizawa T, Azukizawa M, Nishitani K, Murata K, Tanaka M, Ito H, Mimori T, Fujii Y. Kawahara R, et al. Among authors: murata k. Mod Rheumatol. 2020 Nov;30(6):975-981. doi: 10.1080/14397595.2019.1680095. Epub 2019 Oct 28. Mod Rheumatol. 2020. PMID: 31612758
The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study.
Murata K, Hashimoto M, Yamamoto W, Son Y, Amuro H, Nagai K, Takeuchi T, Katayama M, Maeda Y, Ebina K, Hara R, Jinno S, Onishi A, Murakami K, Tanaka M, Ito H, Mimori T, Matsuda S. Murata K, et al. Rheumatol Int. 2020 Feb;40(2):217-225. doi: 10.1007/s00296-019-04464-9. Epub 2019 Oct 16. Rheumatol Int. 2020. PMID: 31620864
3,881 results